TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01849003

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-6615
Description: GS-6615 tablet(s) administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-6615
Description: GS-6615 tablet(s) administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-6615
Description: GS-6615 tablet(s) administered orally
Study: NCT02832921

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive training by virtual reality

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive training by virtual reality

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: watching a scientific TV documentary

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: treadmill
Description: VR cognitive training will be augmented by walking on a treadmill, since it is well established that dual tasking-i.e. performing the VR-based cognitive effort together with a motor task, even as simple as walking on a treadmill-places greater demand on cognitive resources than a single task.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: treadmill
Description: VR cognitive training will be augmented by walking on a treadmill, since it is well established that dual tasking-i.e. performing the VR-based cognitive effort together with a motor task, even as simple as walking on a treadmill-places greater demand on cognitive resources than a single task.
Study: NCT02193724

Intervention type: OTHER
Intervention: Skin Biopsy
Description: A very small skin sample will be taken from the participant's arm. This will only be performed while the patient is under sedation for clinical purposes (e.g. exam under anesthesia, MRI, or other procedure requiring sedation).

Intervention type: OTHER
Intervention: Blood Draw
Description: About 1 teaspoon of blood will be drawn from the participant's arm or from a central line catheter if present. Blood collection will be done at the same time the participant has blood drawn for routine clinical care.
Study: NCT03049215

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lumen Apposing Metal Stent (LAMS)
Description: The AXIOS Stent and Electrocautery-Enhanced Delivery System is an endoscopic device designed to enable the ultrasound trained interventional endoscopist to deliver a transenteric stent between the gastrointestinal tract and a pancreatic pseudocyst.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LAMS plus double pigtail stent
Description: The AXIOS Stent and Electrocautery-Enhanced Delivery System is an endoscopic device designed to enable the ultrasound trained interventional endoscopist to deliver a transenteric stent between the gastrointestinal tract and a pancreatic pseudocyst. The double pigtail stent is a routinely used plastic biliary stent.
Study: NCT01796444

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sentinel Lymph Node Biopsy
Description: Sentinel lymph nodes are identified with the combining use of intraoperative gamma detector and/or blue dye.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel Lymph Node Biopsy
Description: Sentinel lymph nodes are identified with the combining use of intraoperative gamma detector and/or blue dye.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intraoperative Pathological Examination
Description: touch imprint cytology and/or frozen section and/or OSNA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraoperative Pathological Examination
Description: touch imprint cytology and/or frozen section and/or OSNA

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Axillary Lymph Node Dissection
Description: Axillary lymph node dissection involving removal of at least level I and II nodes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pathological Evaluation
Description: H\&E and IHC

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pathological Evaluation
Description: H\&E and IHC

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant Systemic Therapy
Description: Adjuvant systemic therapy was determined by the treating physician according to the recently NCCN.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adjuvant Systemic Therapy
Description: Adjuvant systemic therapy was determined by the treating physician according to the recently NCCN.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Whole-breast opposing tangential-field radiation therapy.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Whole-breast opposing tangential-field radiation therapy.
Study: NCT01922414

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laser
Description: Patients will undergo laser lithotripsy durin PNL

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonic
Description: Patients will undergo ultrasonic lithotripsy during PNL
Study: NCT02278237

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VME Group
Description: Received inhaler education through VME (virtual education module)
Study: NCT03368560

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sudarshan Kriya Yoga
Description: Sudarshan Kriya Yoga (SKY): A 12-week training course conducted by certified instructors from the Art of Living Foundation. SKY training will take place in group-format (group sizes of 8-15 participants) in an appropriately sized and accessible community hall in London, Ontario.SKY training involves attending a week-long (5 days) course that teaches the basic principles of SKY over 2.5-3 hour daily sessions. This will be followed by once weekly follow up sessions (90 min/wk) for 3 weeks and then bimonthly sessions (every 2 weeks) for the next 8 weeks. In addition, participants will be asked to practice SKY at home daily (25 min/day) throughout the duration of the study period and log practice frequency and any other noteworthy observations in a log sheet that will be provided to them . Nutritional snacks will be provided during the 5 day SKY training course.
Study: NCT01491165

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stem cell transplantation through interventional procedures
Description: one time interventional procedures
Study: NCT01391871

Intervention type: DEVICE
Intervention: OCT
Description: Optical coherence tomography

Intervention type: DEVICE
Intervention: OCT
Description: Optical coherence tomography

Intervention type: DEVICE
Intervention: Transthoracic echocardiography CFR measurement
Description: CFR will be assessed using transthoracic echocardiography with adenosine infusion.

Intervention type: DEVICE
Intervention: Transthoracic echocardiography CFR measurement
Description: CFR will be assessed using transthoracic echocardiography with adenosine infusion.
Study: NCT00469027

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: eNOS transfected EPCs will be delivered via a PA line
Description: incremental dosing over 3 days
Study: NCT00666471

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MICE
Description: MICE

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SPA ligation
Description: SPA ligation
Study: NCT01164969

Intervention type: DRUG
Intervention: Antibiotics to which H. pylori can not develope resistance
Description: Amoxicillin, metronidazole and tetracyclin as primary drugs to treat H. pylori infection in duration of 10 days.
Study: NCT02473874

Intervention type: DEVICE
Intervention: Skin Spect dermoscope
Description: Skin imaging

Intervention type: DEVICE
Intervention: Spatially modulated quantitative
Description: Skin imaging
Study: NCT03189953

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 68Ga-NODAGA-exendin 4 PET/CT
Description: 68Ga-NODAGA-exendin 4 PET/CT
Study: NCT02842671

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assigned Ambassador
Description: If assigned to the intervention group, participants will be contacted by the assigned medical student ambassador at least 1 day prior to the procedure. A brief discussion will take place to review the child's history and survey results. The family will be met by the Ambassador at the hospital and stay with the family until the patient is in the post anesthesia recovery unit. The ambassador is expected to make accommodations for the child as determined by the accommodations survey results. The family will be required to allow the Ambassador to stay through check-in and the procedure.
Study: NCT04652843

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Rectosignoidoscopy
Description: Rectosignoidoscopy for colonic biospsies collection

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Rectosignoidoscopy
Description: Rectosignoidoscopy for colonic biospsies collection
Study: NCT00906789

Intervention type: BEHAVIORAL
Intervention: Software
Description: This is an observer performance study. Radiologists will interpret chest radiographs without and then with the Riverain software, both SoftView (TM) OnGuard (TM) CADe Software with be tested
Study: NCT02011503

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Multi-layer compression therapy
Description: Application of multi-layer compression therapy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multi-layer compression therapy
Description: Application of multi-layer compression therapy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Application of dHACM
Description: Application of dHACM to ulcer.
Study: NCT00095303

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Strategic Family Therapy (BSFT)
Description: BSFT is a family therapy approach that consists of 12 to 16 sessions (each 1 to 1.5 hours long) over a 4-month period during the Main Study, and up to 8 booster sessions. Interventions are delivered to adolescents and relevant family members in non-restrictive community settings (e.g., clinics, homes, school).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: TAU varies depending on site, however each will offer services that include at least 1 therapy session (individual or group therapy) per week during the Main Study, as well as participation in ancillary services (e.g., case management, self help groups, etc.) over a four month period.
Study: NCT01364467

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Children aged 7-11 years old will receive placebo 200 mg three times a day (TID), while children older than 12 will receive Placebo 400 mg TID.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Guaifenesin
Description: Children aged 7-11 years old will receive guaifenesin 200 mg TID, while children older than 12 will receive guaifenesin 400 mg TID.
Study: NCT03784430

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate dental implant placement
Description: Tooth will be extracted and a dental implant will be positioned at the same time.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate dental implant placement with CTG
Description: Tooth will be extracted and a dental implant will be positioned at the same time with a connective tissue graft.
Study: NCT05934760

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT)
Description: Each HIIT session last 15 minutes. Participants will be asked to measure their own heart rate during their rest periods and provided with an estimated max heart rate which they should be aiming to achieve within the final 2 exercises. Participants will be provided with a logbook to record the heart rate achieved in each exercise. The regimen will include:~* 2 min warm-up: jogging on the spot~* Each of the following exercises performed for 60seconds, interspaced by 90 seconds rest~  * Star jumps~ * Standing squats~ * On-the-spot sprints~ * Standing squats~ * Star jumps~* 2 min cool-down: jogging on the spot
Study: NCT04652843

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Rectosignoidoscopy
Description: Rectosignoidoscopy for colonic biospsies collection

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Coloscopy
Description: Coloscopy for colonic biospsies collection

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Coloscopy
Description: Coloscopy for colonic biospsies collection

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Coloscopy
Description: Coloscopy for colonic biospsies collection
Study: NCT04356508

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Single dose at 0.3mg/kg
Study: NCT00582179

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Pressure Dressing
Description: If hematoma still draining at 5 days post surgery, patients who randomize to Group A will have a standard pressure dressing applied and checked every 24-48 hours for continued draining. If still draining at 10 days post surgery, patient is at end point of study and must return to OR for Irrigation and Debridement of the wound. If infection occurs, patient is at end point of study and must return to OR for I\&D.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VAC
Description: If hematoma still draining at 5 days post surgery, patients who randomize to Group B will have a VAC negative pressure device applied and checked every 24-48 hours for continued draining. If still draining at 10 days post surgery, patient is at end point of study and must return to OR for Irrigation and Debridement of the wound. If infection occurs, patient is at end point of study and must return to OR for I\&D.
Study: NCT04652843

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Coloscopy
Description: Coloscopy for colonic biospsies collection
Study: NCT02783937

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Filgrastim
Description: Each case will have two intervention phases done blindly at random with a wash-out period of 6 months:~Phase A:~Filgrastim vial (30 million IU/ml) SC injection twice daily for five consecutive days.~Phase B:~Injection of saline SC injection twice daily for five consecutive days.
Study: NCT01094054

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adjustable gastric banding
Description: Placement of adjustable gastric band - laparoscopically

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary and lifestyle modification
Description: Dietary and lifestyle modification~Subjects will meet with a dietitian and a psychologist on a weekly basis and consume a diet matched to that of the banding arm
Study: NCT01385930

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle counseling
Description: Lifestyle counseling
Study: NCT03155503

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SUVN-911
Description: Oral Tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SUVN-911
Description: Oral Tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Oral Tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Oral Tablet
Study: NCT02783937

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Injection of saline SC injection twice daily for five consecutive days
Study: NCT02931539

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maribavir
Description: Maribavir 400 milligrams (mg) (2x200 mg tablets) will be administered twice daily for 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ganciclovir
Description: Ganciclovir as per the investigator's prescribed dosing regimen will be administered for 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Valganciclovir
Description: Valganciclovir as per the investigator's prescribed dosing regimen will be administered for 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Foscarnet
Description: Foscarnet as per the investigator's prescribed dosing regimen will be administered for 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cidofovir
Description: Cidofovir as per the investigator's prescribed dosing regimen will be administered for 8 weeks.
Study: NCT01658878

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Study: NCT05934760

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance based training (RET)
Description: Each RET session lasts an estimated 20minutes. Participants will be provided with a set of resistance bands to provide resistance to their workout, and a logbook to record the number of repetitions and band used.~Each session will include:~* 2 min warm-up jogging on the spot~* 2 sets of 12-15 repetitions of:~* Squats~* Hip flexion~* Hip extension~* Hip abduction~* Seated row~* Bench press~* Lateral raises~* 2 min jogging on the spot cooldown.~Each exercise will be separated by 1-minute rest, with participants encouraged to workout to mild fatigue on their final repetition in each set. If able to perform more than the allocated maximum of 15 repetitions prior to fatigue, then participants will be informed to increase the resistance by using a tougher resistance band.
Study: NCT01658878

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sorafenib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Study: NCT02297893

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dexterity training program (HOMEDEXT)
Description: The dexterity training program contains 7 exercises which focus on improving fine motor skills.
Study: NCT01658878

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Study: NCT03310515

Intervention type: BEHAVIORAL
Intervention: Risk reduction counseling
Description: Subjects will receive comprehensive prevention package including HIV and safe sex counseling, provision of condoms and water-based lubricant, and STI screening and referral for treatment.

Intervention type: OTHER
Intervention: Social harm interview
Description: Information regarding social harms (loss of privacy, stigmatization, interference with gainful employment, and coercion) will be solicited during bi-monthly study visits after enrollment in the study and will be recorded. Subjects who report social harms will be referred to speak with a social worker and/or a study counselor.

Intervention type: OTHER
Intervention: Computer-Assisted Self Interviewing technique
Description: Demographic, behavioral, and psychosocial factors associated with HIV acquisition will be assessed by CASI.
Study: NCT03048279

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2 Group: Participants interviewed by phone and/or mail to obtain medical history specific to their diagnosis of either MEN1 or MEN2.~Close Relatives of Registered MDACC MEN Patients Group: Participants asked to complete a health and family history questionnaire. This questionnaire process may be completed by phone or mail.
Study: NCT02297893

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Theraband training program
Description: The Theraband training program contains 7 exercises which focus on improving upper limb strength
Study: NCT01119040

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Natural Orifice Translumenal Endoscopic Surgery
Description: Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures involve transmural passage of flexible endoscopes introduced via a natural orifice whereby permitting access to the peritoneal cavity while avoiding skin incisions. No clear indication due to a number of physiologic, microbiologic, immunologic, and technical limitations. The concept of NOTES PEG Rescue in the setting of a dislodged naïve PEG tube may spare individual patients the physiologic stress of traditional surgery while concomitantly providing a natural segue to further study the NOTES platform in the human setting. PEG Rescue may represent a unique, practical, and empowering application of the burgeoning experience of natural orifice translumenal endoscopic surgery.
Study: NCT04241003

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SmartDrive Mx2+
Description: Rear-mounted power assist
Study: NCT01647763

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hemorrhoidal artery ligation with rectoanal repair
Description: Hemorrhoidal arteries will be detected using an ultrasound Doppler probe. The arteries will be sutured with at least 4 Z-sutures.~In the area with the 3 largest knots a purse string suture will be placed.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stapled hemorrhoidopexy
Description: A purse string suture will be placed just below the hemorrhoidal cushion. Fixing the suture around the shaft of a circular PPH 03 stapler (Ethicon Endo-Surgery). Hemorrhoids will be removed by firing the stapler. Sufficiency of the stapler line will be examined through a proctoscope. Eventual sources of bleeding will be sutured.
Study: NCT02512796

Intervention type: DRUG
Intervention: Gadolinium contrast dye
Description: Gadolinium contrast dye administered during MRI

Intervention type: DRUG
Intervention: Gadolinium contrast dye
Description: Gadolinium contrast dye administered during MRI
Study: NCT04460027

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Woebot Substance Use Disorder
Description: Woebot Substance Use Disorder is an automated conversational agent, available through a smartphone application, that delivers evidence-based psychotherapeutics, empathy, and emotional health psychoeducation.
Study: NCT00447421

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pemetrexed
Description: Phase 1: 500 mg/m2 then 400 mg/m2, intravenous (IV), every 21 days x 4 cycles (dose escalation)~Phase 2: 500 mg/m2 then phase 1 determined dose, IV, every 21 days x 4 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: Phase 1 and Phase 2: 75 mg/m2, intravenous (IV), every 21 days x 4 cycles

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation
Description: Phase 1 and Phase 2: 50-62 Gy, 25-31 days, cycles 2-4
Study: NCT03714841

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CRP
Description: Knowledge of CRP value

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CRP
Description: Knowledge of CRP value
Study: NCT02471417

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary nitrate
Description: 140ml of nitrate rich beetroot juice provides 12.9mmol nitrate and will be on a single occasion by the study subjects.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 140ml of nitrate depleted beetroot juice provides 0.5mmol nitrate and will be on a single occasion by the study subjects.